The ROE as of December 2024 (TTM) for Indivior PLC (INVVY) is 4.22%

According to Indivior PLC’s latest financial reports and current stock price. The company's current ROE is 4.22%. This represents a change of -97.35% compared to the average of 159.02% of the last 4 quarters.

Indivior PLC (INVVY) Historical ROE (quarterly & annually)

How has INVVY ROE performed in the past?

The mean historical ROE of Indivior PLC over the last ten years is 29.24%. The current 4.22% ROE has changed -85.56% with respect to the historical average. Over the past ten years (40 quarters), INVVY's ROE was at its highest in in the September 2023 quarter at 542.54%. The ROE was at its lowest in in the December 2022 quarter at -367.99%.

Indivior PLC (INVVY) ROE by Quarter and Year

Discovering the peaks and valleys of Indivior PLC ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Indivior PLC (INVVY) Average ROE

How has INVVY ROE performed in the past?

The current ROE of Indivior PLC (INVVY) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Indivior PLC (INVVY) ROE vs. Peers

How is INVVY’s ROE compared to its peers?

Indivior PLC’s ROE is greater than Orexo AB (publ) (-359.08%), less than Genomma Lab Internacional, S.A.B. de C.V. (15.66%), less than Hypera S.A. (13.22%), greater than Sumitomo Pharma Co., Ltd. (-144.30%), less than Elanco Animal Health Incorporated (3.31%), less than SIGA Technologies, Inc. (49.06%), less than Esperion Therapeutics, Inc. (23.71%), greater than Catalent, Inc. (-11.44%), less than Neurocrine Biosciences, Inc. (15.68%), less than Amphastar Pharmaceuticals, Inc. (22.92%), less than Collegium Pharmaceutical, Inc. (40.81%), greater than Ironwood Pharmaceuticals, Inc. (-7.63%), greater than ANI Pharmaceuticals, Inc. (-1.60%), greater than Alpha Teknova, Inc. (-37.32%), less than Guardion Health Sciences, Inc. (77.24%), less than Lifecore Biomedical, Inc. (17.23%), greater than Organogenesis Holdings Inc. (-2.69%), greater than Petros Pharmaceuticals, Inc. (-122.55%), greater than Pacira BioSciences, Inc. (-10.70%), greater than Intra-Cellular Therapies, Inc. (-9.93%), less than Alkermes plc (26.49%), less than Eagle Pharmaceuticals, Inc. (17.39%),

Build a custom stock screener for Indivior PLC (INVVY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Indivior PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Indivior PLC (INVVY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Indivior PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.